早期目標導向治療在感染性休克中應用－台灣氫水實驗室

儘管是針對早期目標導向治療在感染性休克中應用,作者提到氫可能在早期治療中具有重要價值,作者大膽提出設想,值得從事感染性休克的同行關注氫氣的生物學效應.

Recently published papers: More about EGDT, experimental
therapies and some inconvenient truths

Abstract
This issue's recently published papers concentrates on early goal
directed therapy, starting with new data from the original study
through to new studies that may have a major bearing on the
treatment of septic shock in years to come. A timely reminder
about talking, walking and teaching clinical medicine completes the
roundup.
Early goals
No one is likely to argue with the belief that prompt and
appropriate treatment is effective and should be the standard
of care. Back in 2001, Emmanuel Rivers and colleagues
published their landmark study of Early Goal Directed
Therapy (EGDT) [1]. Perhaps the central concept behind
EGDT is that of oxygen debt and the secondary inflammatory
insult inflicted by tissue hypoxia, which is modifiable with
timely and aggressive cardiovascular support. A series of
recently published papers emphasise and further elucidate
this idea .
Firstly, Rivers and colleagues have published the results of a
study of serum biomarkers of systemic inflammation from the
majority of patients from their original study [2]. Patients had
multiple biomarkers measured periodically over the first 72
hours of their illness. Two separate comparative analyses
were performed. First, the protocol group are considered
against the standard care group. Second, the whole patient
population has been stratified into three groups by severity of
admission global dysoxia (serum lactate and central venous
oxygen saturations) and compared. Unfortunately, no third
analysis of these three groups separated into those in the
protocol and standard care groups was performed. Although
this post hoc separation would have yielded statistically small
groups, the results may well have provided useful hypothesis
generation rather than statistically significant results. The
results of the treatment comparison analysis demonstrate a
statistically significant reduction in the level of all markers in

全文

台灣氫水實驗室 TEL:0963-210-763

email: ddh2water@gmail.com LINE ID:h2water

台灣氫水實驗室部落格:http://blog.xuite.net/hworker77086600/twblog

歡迎來電索取氫水辨認方法(防止喝到傷身的假氫水)

氫水,氫分子、氫氣、健康氫水,水素水,負電位,ORP,抗氧化,抗自由基,氫分子醫學,氫水,Hydrogen water,氫氣、氫,台灣氫水研究中心,氫思語,孫學軍,太田成男,鹼性離子水,小分子水,能量水,電解水,富氫水,負氫水,活水,健康,養生,活力,大氫鬆,小氫鬆,氫水機,水素,水素水機,王群光,氫氧機,綠加利,活美水素水,低氘水,活性原子氫,富氫水,負氫水,每日水素,活氫水,氫氧造水機,百樂,負氫,氫博士,氫水棒,氫源,新德美,HOH,鹼性活氫水,氫美機,負氫離子水,氫氣棒,呼吸氫氣,氫氧療法,加氫水,氫水、健康氫水、水素水、負電位、ORP、抗氧化、抗自由基、氫分子醫學、氫水、Hydrogen water、氫氣、氫、氫水、台灣氫水實驗室、台灣氫水研究中心、氫思語、孫學軍、太田成男、鹼性離子水、小分子水、能量水、電解水、富氫水、負氫水、活水、健康、養生、活力、大氫鬆、小氫鬆、氫水機、水素、水素水機、王群光、氫氧機、綠加利、活美水素水、低氘水、活性原子氫、富氫水、負氫水、每日水素、活氫水、氫氧造水機、百樂、負氫、氫博士、氫水棒、氫源、新德美、HOH、鹼性活氫水、氫美機、負氫離子